Saad Al-Kadhi, MD
Ophthalmology · Champaign, ILNPI 1154852473
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,020 of the $1,461 with a category attached, or 69.8%. Alcon accounts for 69.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $1,020 and has fallen 87.0% since, to $133 in 2025. That places this record below the midpoint for ophthalmology clinicians in IL, where the typical reported total is $1,164.
Across 14 payments — averaging $104.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$1K
- Genentech USA, Inc.$146
- Astellas Pharma US Inc$120
- AbbVie$95
- Coherus Oncology, Inc.$32
- Apellis Pharmaceuticals, Inc.$31
- plus $17 from 1 others
What the payments were for
- Travel & lodging$1,02070%
- Food & beverage$42329%
- Education$171%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 1 | $1,020 |
| Genentech USA, Inc. | 1 | $146 |
| Astellas Pharma US Inc | 4 | $120 |
| AbbVie | 4 | $95 |
| Coherus Oncology, Inc. | 1 | $32 |
| Apellis Pharmaceuticals, Inc. | 2 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VABYSMO$146
How this compares
$1,461 in reported general payments places this provider in the 50th percentile of 773 ophthalmology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 28 | $1,765 |
| Ketorolac Tromethamine | 18 | $899 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 13 | $158 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Champaign
- Seenu HariprasadChicago$2.3M
- Lisa NijmSpringfield$1.7M
- Kathleen MornoNorth Riverside$1.2M
- Veeral ShethOak Forest$716K
- James KatzDes Plaines$642K
- Mitchell JacksonLake Villa$584K
- David LubeckHomewood$575K
- Parag MajmudarHighland Park$451K
- Daniel OwensLombard$343K
- Yannek LeidermanChicago$312K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.